In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin). Some people may refer to these as ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. In Chimamanda Ngozi Adichie’s latest novel Dream Count, one of the protagonists, Chiamaka, has a ...